<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="129425">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01889576</url>
  </required_header>
  <id_info>
    <org_study_id>IDS BE-02-RG-219</org_study_id>
    <nct_id>NCT01889576</nct_id>
  </id_info>
  <brief_title>The Effect of Magnesium on Early Post-transplantation Glucose Metabolism</brief_title>
  <official_title>The Effect of Magnesium Supplements on Early Post-transplantation Glucose Metabolism: a Randomized Controlled Trial.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Ghent</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Astellas Pharma Inc</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Ghent</source>
  <oversight_info>
    <authority>Belgium: Ethics Committee</authority>
    <authority>Belgium: Federal Agency for Medicinal Products and Health Products</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Hypomagnesemia is common early after transplantation, especially in association with
      calcineurin inhibitors and predicts diabetes after transplantation. Magnesium improves
      glycemic control and insulin sensitivity in diabetics and insulin resistant subjects without
      diabetes but this was never evaluated in transplant recipients.

      The aim of the study is to assess whether magnesium improves glycemic control and insulin
      sensitivity early after transplantation.

      The study is an open label study in which adult hypomagnesemic renal transplant recipients
      are randomized the first 2 weeks after kidney transplantation to magnesium oxide  or no
      supplementation.

      The hypothesis is that magnesium supplementation in renal transplant recipients exerts a
      beneficial effect on glycemia and the development of diabetes after transplantation.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2010</start_date>
  <completion_date type="Actual">September 2012</completion_date>
  <primary_completion_date type="Actual">June 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Fasting glycemia, 3 months after transplantation.</measure>
    <time_frame>3 months after transplantation.</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Incidence of diabetes after transplantation the first 3 months after transplantation.</measure>
    <time_frame>3 months after transplantation.</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of impaired fasting glucose the first 3 months after transplantation.</measure>
    <time_frame>3 months after transplantation.</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Insulin sensitivity measured by &quot;Homeostatic Model assessment (HOMA)&quot;, 3 months after transplantation.</measure>
    <time_frame>3 months after transplantation.</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">54</enrollment>
  <condition>Glucose Metabolism After Transplantation</condition>
  <arm_group>
    <arm_group_label>Supplementation of Magnesium oxide.</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Supplementation of magnesium oxide (450 mg up to 3 times daily maximum), aiming at a serum magnesium concentration of &gt;= 1,9 mg/dL).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No supplementation or minimal dose.</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>No supplementation (or a minimal dose to keep serum magnesium concentration â‰¥ 1.2mg/dL depending on the treating physician).</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Magnesium Oxide</intervention_name>
    <arm_group_label>Supplementation of Magnesium oxide.</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Renal transplantation recipients

          -  &gt; 18 years of age

          -  Less than 2 weeks post-transplantation

          -  Hypomagnesemia &lt; 1,7 milligram/deciliter on 2 consecutive blood samples (laboratory
             reference interval 1,7 - 2,55 milligram/deciliter).

        Exclusion Criteria:

          -  Pre-existing diabetes mellitus defined as the intake of anti-diabetic drugs at the
             time of inclusion

          -  Serum creatinine &gt; 3 milligram/deciliter

          -  Active infection (C reactive protein &gt; 3 milligram/deciliter)

          -  Severe hypomagnesemia (&lt; 1,2 milligram/deciliter)

          -  Hypokalemia (&lt; 3,5 milli-equivalent/liter)

          -  Severe hypocalcemia (&lt; 6,5 milligram/deciliter)
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Steven Van Laecke, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ghent University Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Ghent University Hospital</name>
      <address>
        <city>Ghent</city>
        <zip>9000</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>June 2013</verification_date>
  <lastchanged_date>June 27, 2013</lastchanged_date>
  <firstreceived_date>June 25, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>glucose</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Magnesium Oxide</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
